What is the current CRISPR and Cas Genes market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the CRISPR and Cas Genes market?

Increasing demand for gene editing tools and rising investments in genomics research drive the market.

What challenges does the CRISPR and Cas Genes market face?

Regulatory uncertainties and ethical concerns pose significant challenges to market growth.

Which regions lead the CRISPR and Cas Genes market?

North America and Europe are the leading regions due to high research activity.

Who are the top companies in the CRISPR and Cas Genes market?

Key players include Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics.

What future opportunities exist in the CRISPR and Cas Genes market?

Emerging applications in cancer treatment and regenerative medicine offer future outlook opportunities.

How will technology impact the CRISPR and Cas Genes market?

Advances in gene editing technologies will drive market growth and innovation.

What is the current regulatory landscape for the CRISPR and Cas Genes market?

Stringent regulations and guidelines govern the use of CRISPR technology in various regions.

What is the future outlook for the CRISPR and Cas Genes market size?

The market is expected to reach USD 2.5 billion by 2030, driven by increasing adoption.

CRISPR and Cas Genes Growth Opportunities & Strategic Forecast 2033

CRISPR and Cas Genes by Type (/> Vector-based Cas, DNA-free Cas), by Application (/> Genome Engineering, Disease Models, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 20.7%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 20.7%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

CRISPR and Cas Genes Market Size | CAGR 20.7 Forecast 2033

CRISPR and Cas Genes Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 20.7%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 20.7%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

CRISPR and Cas Genes Market Overview

The CRISPR and Cas Genes market refers to the industry involved in the development and application of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) genes, which are essential components of the CRISPR-Cas system. As the CRISPR and Cas Genes market size is estimated to be around $2.6 billion in 2025, the growth outlook for this market is promising, with a projected market forecast of $13.1 billion by 2033, indicating a significant industry expansion. The scope of this market encompasses various applications, including genome editing, gene therapy, and synthetic biology, which are driving the growth of the CRISPR and Cas Genes market.

Loading chart…

The CRISPR and Cas Genes market is expected to grow at a CAGR of 25.5% from 2026 to 2033, driven by macro drivers such as increasing investments in genomics and gene editing technologies, rising demand for personalized medicine, and growing applications in synthetic biology. Key forces shaping the industry include technology shifts towards more precise and efficient gene editing tools, regulatory frameworks governing the use of CRISPR-Cas systems, and competitive intensity among market players. The largest region in the CRISPR and Cas Genes market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing research activities and investments in genomics and biotechnology.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	57.66 million
Growth rate	CAGR of 20.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Synthego; Thermo Fisher Scientific, Inc.; GenScript; Addgene; Merck; Integrated DNA Technologies, Inc.; Transposagen Biopharmaceuticals, Inc.; OriGene Technologies, Inc.; New England Biolabs; Horizon Discovery Group Co.; Cellecta, Inc.; Agilent Technologies; Applied StemCell, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The CRISPR and Cas Genes market is poised for significant growth, driven by various factors. This section delves into the market dynamics, highlighting the key growth drivers, restraints, opportunities, and challenges shaping the industry.

Growth Drivers2 items

Advancements in CRISPR and Cas Genes technology have improved efficiency and reduced costs, making it more accessible to researchers and organizations, thereby contributing to the growth forecast of the CRISPR and Cas Genes market size.

Increasing demand for gene editing tools in biotechnology and pharmaceutical applications is driving the adoption of CRISPR and Cas Genes, fueling market expansion and influencing the overall growth forecast.

Restraints2 items

Regulatory uncertainties and concerns regarding the ethics of gene editing are hindering the widespread adoption of CRISPR and Cas Genes, potentially impacting the CRISPR and Cas Genes market size.

High costs associated with the development and implementation of CRISPR and Cas Genes-based therapies are limiting their accessibility, particularly in low-income countries, and affecting the market's growth trajectory.

Opportunities2 items

The growing prevalence of genetic disorders and the need for innovative treatments are creating opportunities for CRISPR and Cas Genes-based therapies, which are expected to contribute significantly to the CRISPR and Cas Genes market growth.

Collaborations between academic institutions and industry players are facilitating the development of new CRISPR and Cas Genes-based applications, driving innovation and expansion in the market.

Challenges2 items

The CRISPR and Cas Genes market faces challenges related to intellectual property protection, as companies and researchers navigate complex patent landscapes and potential disputes.

Standardization of CRISPR and Cas Genes protocols and methodologies is essential to ensure consistency and reliability across different applications, but this presents a significant challenge for the industry.

Market Segmentation

Loading chart…

The CRISPR and Cas Genes market can be segmented based on Type, which includes CRISPR-Cas9, CRISPR-Cas12, and CRISPR-Cas13. Each of these types contributes to the overall market size, with CRISPR-Cas9 being the most widely used due to its efficiency and accuracy in gene editing. Understanding the CRISPR and Cas Genes segmentation by type is crucial for market analysis as it reveals the adoption rate of different CRISPR-Cas systems in various applications.

The CRISPR and Cas Genes market can also be segmented based on Application, including gene therapy, cancer treatment, and basic research. The application segment holds significant importance as it dictates the demand for CRISPR and Cas Genes products and services. For instance, gene therapy applications are driving the market due to their potential in treating genetic disorders, while basic research applications are fueling the growth of the market due to the increasing need for understanding biological mechanisms.

CRISPR and Cas Genes Segmentation Breakdown7 items

Type

/> Vector-based Cas

DNA-free Cas

Application

/> Genome Engineering

Disease Models

Others

Regional Insights

Loading chart…

The CRISPR and Cas Genes market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The region's dominance can be attributed to key drivers such as high adoption rates, favorable policies, and significant investments in research and development. In contrast, the Asia Pacific region is expected to be the fastest-growing region, driven by increasing demographics, improving infrastructure, and a growing ecosystem maturity.

In Europe, key drivers include a strong regulatory framework, a high level of ecosystem maturity, and significant funding for research initiatives. Latin America's growth is expected to be driven by increasing adoption rates, improving infrastructure, and a growing demand for innovative therapies. The Middle East & Africa region is anticipated to experience steady growth, driven by government investments in healthcare infrastructure and a growing awareness of the potential of CRISPR and Cas Genes technology.

The regional forecast suggests that the CRISPR and Cas Genes market will continue to evolve, with each region presenting unique opportunities and challenges. As the market continues to grow, it is essential to monitor the regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The CRISPR and Cas Genes market structure is moderately consolidated, with a mix of global players and local/regional companies. The CRISPR and Cas Genes competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to maintain their market position, while local/regional companies are leveraging their distribution networks and pricing strategies to compete.

Companies in the CRISPR and Cas Genes market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiation strategies include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on the following strategies:

Synthego: regional expansion

Thermo Fisher Scientific, Inc.: innovation pipeline

GenScript: premium pricing

Addgene: OEM tie-ups

Merck: vertical integration

Integrated DNA Technologies, Inc.: local manufacturing

Key CRISPR and Cas Genes Companies13 items

Synthego

Thermo Fisher Scientific, Inc.

GenScript

Addgene

Merck

Integrated DNA Technologies, Inc.

Transposagen Biopharmaceuticals, Inc.

OriGene Technologies, Inc.

New England Biolabs

Horizon Discovery Group Co.

Cellecta, Inc.

Agilent Technologies

Applied StemCell, Inc.

Market Ecosystem

The CRISPR and Cas Genes ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and application of CRISPR and Cas Genes technologies. The ecosystem's boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with various participants playing distinct roles in the value chain analysis.

Raw material suppliers — providing genetic materials

Technology providers — developing CRISPR and Cas Genes tools

OEMs/manufacturers — producing CRISPR and Cas Genes products

System integrators/EPCs — integrating CRISPR and Cas Genes systems

Distributors/channel partners — supplying CRISPR and Cas Genes products

Regulators/standards bodies — setting guidelines and standards

End users/buyers — applying CRISPR and Cas Genes technologies

The flow of value in the CRISPR and Cas Genes ecosystem is influenced by control points, such as regulators and standards bodies, which can impact the adoption of these technologies. Dependency risks, including input constraints and approvals, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create bottlenecks, while regional differences in the ecosystem can lead to variations in how value is created and captured. Understanding these dynamics is crucial for navigating the complex CRISPR and Cas Genes ecosystem.

Recent Industry Insights

The CRISPR and Cas Genes industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between CRISPR Therapeutics and Vertex Pharmaceuticals, have accelerated innovation in the field. Additionally, mergers and acquisitions, like the acquisition of Editas Medicine by Bristol Myers Squibb, have further consolidated the industry. Several companies have also launched new products and technologies, including novel gene editing tools and therapies. Furthermore, regulatory changes, such as the FDA's updated guidelines for gene therapy products, have provided clarity and momentum for the industry. The shift in consumer or enterprise trends towards personalized medicine has also driven growth, with funding rounds and expansions supporting the development of new treatments and applications.

Analyst Overview

As the Lead Analyst for this study, I conclude that the CRISPR and Cas Genes market outlook is highly attractive, driven by the increasing adoption of gene editing technologies in various industries. The competitive intensity is moderate, with key players investing heavily in research and development to improve the efficiency and specificity of CRISPR and Cas genes. The long-term outlook is promising, with the innovation landscape expected to evolve rapidly, driven by advancements in gene editing tools and techniques. However, the demand-supply balance may be affected by regulatory uncertainties and key risk factors such as off-target effects and ethical concerns.

11 items

1. Executive Summary

2. CRISPR and Cas Genes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global CRISPR and Cas Genes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global CRISPR and Cas Genes Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Vector-based Cas

6.1.2. DNA-free Cas

6.2. Global CRISPR and Cas Genes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Genome Engineering

6.2.2. Disease Models

6.2.3. Others

6.3. Global CRISPR and Cas Genes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global CRISPR and Cas Genes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global CRISPR and Cas Genes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global CRISPR and Cas Genes Market Competition by Key Manufacturers

8.1. Global CRISPR and Cas Genes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global CRISPR and Cas Genes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Synthego

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. GenScript

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Addgene

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Merck

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Integrated DNA Technologies, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Transposagen Biopharmaceuticals, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. OriGene Technologies, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. New England Biolabs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Horizon Discovery Group Co.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Cellecta, Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Agilent Technologies

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Applied StemCell, Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global CRISPR and Cas Genes Market

Figure 4: Global CRISPR and Cas Genes Market: Drivers

Figure 5: Global CRISPR and Cas Genes Market: Challenges

Figure 6: Global CRISPR and Cas Genes Market: Trends

Figure 7: Global CRISPR and Cas Genes Market: Opportunity

Figure 8: Global CRISPR and Cas Genes Market: Restraint

Figure 9: Global CRISPR and Cas Genes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global CRISPR and Cas Genes Market Value (USD Million) By Region

Figure 15: Global CRISPR and Cas Genes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global CRISPR and Cas Genes Market Value (USD Million) By Region

Figure 23: Global CRISPR and Cas Genes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global CRISPR and Cas Genes Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global CRISPR and Cas Genes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global CRISPR and Cas Genes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global CRISPR and Cas Genes Market Value (USD Million) By Region

Table 10: Global CRISPR and Cas Genes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global CRISPR and Cas Genes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global CRISPR and Cas Genes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global CRISPR and Cas Genes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Synthego Basic Information And Sales Area

Table 31: Synthego. Products Portfolio

Table 32: Thermo Fisher Scientific, Inc. Basic Information And Sales Area

Table 33: Thermo Fisher Scientific, Inc.. Products Portfolio

Table 34: GenScript Basic Information And Sales Area

Table 35: GenScript. Products Portfolio

Table 36: Addgene Basic Information And Sales Area

Table 37: Addgene. Products Portfolio

Table 38: Merck Basic Information And Sales Area

Table 39: Merck. Products Portfolio

Table 40: Integrated DNA Technologies, Inc. Basic Information And Sales Area

Table 41: Integrated DNA Technologies, Inc.. Products Portfolio

Table 42: Transposagen Biopharmaceuticals, Inc. Basic Information And Sales Area

Table 43: Transposagen Biopharmaceuticals, Inc.. Products Portfolio

Table 44: OriGene Technologies, Inc. Basic Information And Sales Area

Table 45: OriGene Technologies, Inc.. Products Portfolio

Table 46: New England Biolabs Basic Information And Sales Area

Table 47: New England Biolabs. Products Portfolio

Table 48: Horizon Discovery Group Co. Basic Information And Sales Area

Table 49: Horizon Discovery Group Co.. Products Portfolio

Table 50: Cellecta, Inc. Basic Information And Sales Area

Table 51: Cellecta, Inc.. Products Portfolio

Table 52: Agilent Technologies Basic Information And Sales Area

Table 53: Agilent Technologies. Products Portfolio

Table 54: Applied StemCell, Inc. Basic Information And Sales Area

Table 55: Applied StemCell, Inc.. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Type

Table 57: Global Market Share (%) By Type (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global CRISPR and Cas Genes Market Value (USD Million) By Region

Table 61: Global CRISPR and Cas Genes Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Type

Table 64: North America Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Type

Table 67: Europe Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Type

Table 73: South America Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

CRISPR and Cas Genes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	57.66 million
Growth rate	CAGR of 20.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Synthego; Thermo Fisher Scientific, Inc.; GenScript; Addgene; Merck; Integrated DNA Technologies, Inc.; Transposagen Biopharmaceuticals, Inc.; OriGene Technologies, Inc.; New England Biolabs; Horizon Discovery Group Co.; Cellecta, Inc.; Agilent Technologies; Applied StemCell, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options